A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma

Hum Gene Ther. 2001 Jul 20;12(11):1459-80. doi: 10.1089/104303401750298616.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Cancer Vaccines
  • Clinical Protocols*
  • Clinical Trials, Phase I as Topic
  • Female
  • Humans
  • Informed Consent
  • Injections, Intralesional / methods
  • Lymph Nodes / pathology
  • Male
  • Maximum Tolerated Dose
  • Melanoma / therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Skin Neoplasms / therapy*
  • Statistics as Topic
  • Time Factors
  • Vaccines, Synthetic / adverse effects
  • Vaccines, Synthetic / therapeutic use*

Substances

  • Cancer Vaccines
  • Vaccines, Synthetic
  • rV-Tricom